Glp-1 (9-36) methods and compositions

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/00 (2006.01)

Patent

CA 2550217

Methods of inhibiting hyperglycemia-induced or free fatty acid-induced reactive oxygen formation in mammalian cells and mammals using the degradation product of glucagon-like peptide 1, GLP-1 (9-36) are provided. Various GLP-1 (9-36) compositions are also provided.

Cette invention concerne des méthodes propres à inhiber la formation d'oxygène réactif induite par hyperglycémie ou par a présence d'acides gras libres dans des cellules de mammifères et des mammifères utilisant le produit de dégradation du peptide 1, GLP-1 (9-36) de type glucacon. Sont également décrites diverses compositions de GLP-1 (9-36).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Glp-1 (9-36) methods and compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glp-1 (9-36) methods and compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glp-1 (9-36) methods and compositions will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1726694

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.